BB

Bhagwan Bhauso Kidgaonkar

Active Director Director DIN 10465142
DIN 10465142 First appointment Jan 2024 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhagwan Bhauso Kidgaonkar

Data last updated:

Bhagwan Bhauso Kidgaonkar is a Director at Lowpay Pharmaceuticals Limited (since 2024). The company operates in Paper.

DIN 10465142
Primary Designation Director
Industry Paper
First Appointment 15 Jan 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lowpay Pharmaceuticals Limited U21009PN2024PLC227261
Director15 Jan 20242024Active

Directorship timeline

Open interactive timeline →
Lowpay Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Bhagwan Bhauso Kidgaonkar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhagwan Bhauso Kidgaonkar

Bhagwan Bhauso Kidgaonkar currently holds 1 directorship: Lowpay Pharmaceuticals Limited (Director, since 15 Jan 2024).

Bhagwan Bhauso Kidgaonkar was first appointed on 15 Jan 2024 as Director at Lowpay Pharmaceuticals Limited.

The current boards of Bhagwan Bhauso Kidgaonkar's companies include Rahul Rajaram Bramhadande (Lowpay Pharmaceuticals Limited), Rutuja Dadaso Kadvekar (Lowpay Pharmaceuticals Limited), Rutvik Ashok Surve (Lowpay Pharmaceuticals Limited), Sachin Damodar Kulkarni (Lowpay Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available